Attached files
| file | filename |
|---|---|
| EX-99.1 - HNO International, Inc. | v196072_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): September 6, 2010
Clenergen
Corporation
(Exact
name of registrant as specified in its charter)
|
Nevada
|
333-130286
|
20-2781289
|
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
|
of
incorporation)
|
File
Number)
|
Identification
No.)
|
|
5379
Lyons Road, Suite 301
|
||
|
Coconut
Creek, Florida
|
33073
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: 954-509-9830
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Introductory
Comment - Use of Terminology
Throughout
this Current Report on Form 8-K, the terms the “Company,” “we,” “us” and “our”
refers to the registrant, Clenergen Corporation, and its wholly-owned
subsidiaries, including Clenergen India Private Limited (“Clenergen India”), on
a consolidated basis.
|
Item
8.01
|
Other
Events.
|
On
September 6, 2010, we forwarded a letter to recent investors in our company who
purchased shares of our common stock in an offering conducted through a sales
agent located in Germany. The letter, which is in both English and
German, is attached as Exhibit 99.1 to this Current Report on Form
8-K.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
The
following exhibits are being filed as part of this Current Report on Form
8-K.
|
Exhibit
Number
|
Exhibit Description
|
|
|
99.1
|
Letter
to investors, forwarded on September 6,
2010.
|
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Dated: September
6, 2010
|
Clenergen
Corporation
|
|
|
By:
|
/s/ Tim J.E. Bowen
|
|
|
Tim
J.E. Bowen
|
||
|
Chief
Executive Officer
|
||
3